Skip to main content

Table 2 Treatment characteristics at the time of RI

From: A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience

 

Number

Percent

Surgery

 Postoperative RI + systemic therapy

9

33

 Postoperative RI alone

3

11

Definitive RI without surgery

  

 RI + systemic therapy

12

45

 RI alone

2

7

Palliative RI

1

4

Concurrent chemotherapy/targeted therapy

 Cisplatin-based

19

70

 Cetuximab

2

7

 None

6

22

  1. Abbreviation: RI re-irradiation